Dr Peter Bryan Schrier, MD in Flushing, NY - Medicare Nephrology

Dr Peter Bryan Schrier, MD is a medicare enrolled "Internal Medicine - Nephrology" physician in Flushing, New York. He went to State University Of Ny Upstate Medical University and graduated in 2007 and has 17 years of diverse experience with area of expertise as Nephrology. He is a member of the group practice Park Avenue Nephrology And Medicine Pc, Wyckoff Professional Medical Services Pc and his current practice location is 15352 76th Rd Unit Cf1, Flushing, New York. You can reach out to his office (for appointments etc.) via phone at (718) 820-0120.

Dr Peter Bryan Schrier is licensed to practice in New York (license number 255487) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1437390515.

Contact Information

	Dr Peter Bryan Schrier, MD
	15352 76th Rd Unit Cf1, Flushing, NY 11367-3183
	(718) 820-0120
	(718) 820-0121

Physician's Profile

Full Name	Dr Peter Bryan Schrier
Gender	Male
Speciality	Nephrology
Experience	17 Years
Location	15352 76th Rd Unit Cf1, Flushing, New York
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Peter Bryan Schrier attended and graduated from State University Of Ny Upstate Medical University in 2007

NPI Data:

NPI Number: 1437390515
Provider Enumeration Date: 03/18/2009
Last Update Date: 08/22/2022

Medicare PECOS Information:

PECOS PAC ID: 2668612102
Enrollment ID: I20130719000003

Medical Identifiers

Medical identifiers for Dr Peter Bryan Schrier such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1437390515	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RN0300X	Internal Medicine - Nephrology	255487 (New York)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Bronx River Nephro Care At The Plaza Rehab & Nursing Center	Bronx, NY	Dialysis facility
Usrc South Flushing	Flushing, NY	Dialysis facility
Atlas Park Dialysis	Glendale, NY	Dialysis facility
Wyckoff Heights Medical Center	Brooklyn, NY	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Park Avenue Nephrology And Medicine Pc	0840430344	5
Wyckoff Professional Medical Services Pc	6406748607	145

News Archive

Study compares new cardiopulmonary resuscitation with standard CPR in cardiac arrest

Continuous chest compression, touted as the new way to perform cardiopulmonary resuscitation, was not an improvement over standard CPR, according to findings published in the New England Journal of Medicine today. The University of Alabama at Birmingham was one of eight United States and Canadian universities involved in the study, the largest such study of out-of-hospital cardiac arrest ever conducted.

Formedix's design tools integrated with Nextrials' EDC and clinical trial data management platform

Nextrials, Inc., a leader in clinical research software and services, today announced that its electronic data capture (EDC) and clinical trial data management platform, Prism™, is now integrated with the study design tools offered by Formedix. Formedix's industry leading Origin™ products include database design tools based on the data standards developed by the Clinical Data Interchange Standards Consortium (CDISC), a platform that Nextrials fully supports.

Obesity linked with greater symptomatic severity of multiple sclerosis

Obesity is an aggravating factor in relapsing-remitting multiple sclerosis, the most common form of the disease.

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

A preclinical study led by researchers at Children's National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy.

Bayer's radium-223 chloride Phase III trial in CRPC, bone metastases meet primary endpoint

Bayer HealthCare Pharmaceuticals Inc. today announced that the Phase III ALSYMPCA trial evaluating Bayer's investigational compound, radium-223 chloride, which is exclusively licensed from Algeta ASA, in patients with castration-resistant prostate cancer (CRPC) and bone metastases met its primary endpoint by significantly improving overall survival.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Peter Bryan Schrier allows following entities to bill medicare on his behalf.

Entity Name	Wyckoff Professional Medical Services Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1659710796 PECOS PAC ID: 6406748607 Enrollment ID: O20040324001805

News Archive

Study compares new cardiopulmonary resuscitation with standard CPR in cardiac arrest

Formedix's design tools integrated with Nextrials' EDC and clinical trial data management platform

Obesity linked with greater symptomatic severity of multiple sclerosis

Obesity is an aggravating factor in relapsing-remitting multiple sclerosis, the most common form of the disease.

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

A preclinical study led by researchers at Children's National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy.

Bayer's radium-223 chloride Phase III trial in CRPC, bone metastases meet primary endpoint

Entity Name	Park Avenue Nephrology & Medicine Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1225389331 PECOS PAC ID: 0840430344 Enrollment ID: O20130705000047

Study compares new cardiopulmonary resuscitation with standard CPR in cardiac arrest

Formedix's design tools integrated with Nextrials' EDC and clinical trial data management platform

Obesity linked with greater symptomatic severity of multiple sclerosis

Obesity is an aggravating factor in relapsing-remitting multiple sclerosis, the most common form of the disease.

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

A preclinical study led by researchers at Children's National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy.

Bayer's radium-223 chloride Phase III trial in CRPC, bone metastases meet primary endpoint

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Peter Bryan Schrier is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Peter Bryan Schrier, MD 1820 E Ray Rd Ste B201, Chandler, AZ 85225-8720 Ph: (480) 935-3991	Dr Peter Bryan Schrier, MD 15352 76th Rd Unit Cf1, Flushing, NY 11367-3183 Ph: (718) 820-0120

News Archive

Study compares new cardiopulmonary resuscitation with standard CPR in cardiac arrest

Formedix's design tools integrated with Nextrials' EDC and clinical trial data management platform

Obesity linked with greater symptomatic severity of multiple sclerosis

Obesity is an aggravating factor in relapsing-remitting multiple sclerosis, the most common form of the disease.

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

A preclinical study led by researchers at Children's National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy.

Bayer's radium-223 chloride Phase III trial in CRPC, bone metastases meet primary endpoint

Internal Medicine Doctors in Flushing, NY

Ms. Min Cai, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4105 College Point Blvd, Suite 1c, Flushing, NY 11355 Phone: 718-321-0558 Fax: 718-321-1672
Dr. David Scott Rubin, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13847 Horace Harding Expy, Flushing, NY 11367 Phone: 718-461-5813 Fax: 718-321-8095
Xueshu Zhang, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 133-47 Sanford Avenue, Suite 1f, Flushing, NY 11355 Phone: 718-359-5780 Fax: 718-359-5821
Haoxu Ouyang, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13227 41st Rd # 2c, Flushing, NY 11355 Phone: 718-269-5055
Mu-i Karen Kuo, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 13259 41st Rd, Suite Cb, Flushing, NY 11355 Phone: 718-939-6234 Fax: 718-939-6235
Evan Choi, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-2000
Dr. Mustafa Salehmohamed, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Wa-100, Flushing, NY 11355 Phone: 718-670-1405

Dr Peter Bryan Schrier, MD - Medicare Nephrology in Flushing, NY

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Study compares new cardiopulmonary resuscitation with standard CPR in cardiac arrest

Formedix's design tools integrated with Nextrials' EDC and clinical trial data management platform

Obesity linked with greater symptomatic severity of multiple sclerosis

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

Bayer's radium-223 chloride Phase III trial in CRPC, bone metastases meet primary endpoint

Medicare Reassignments

Study compares new cardiopulmonary resuscitation with standard CPR in cardiac arrest

Formedix's design tools integrated with Nextrials' EDC and clinical trial data management platform

Obesity linked with greater symptomatic severity of multiple sclerosis

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

Bayer's radium-223 chloride Phase III trial in CRPC, bone metastases meet primary endpoint

Study compares new cardiopulmonary resuscitation with standard CPR in cardiac arrest

Formedix's design tools integrated with Nextrials' EDC and clinical trial data management platform

Obesity linked with greater symptomatic severity of multiple sclerosis

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

Bayer's radium-223 chloride Phase III trial in CRPC, bone metastases meet primary endpoint

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Study compares new cardiopulmonary resuscitation with standard CPR in cardiac arrest

Formedix's design tools integrated with Nextrials' EDC and clinical trial data management platform

Obesity linked with greater symptomatic severity of multiple sclerosis

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

Bayer's radium-223 chloride Phase III trial in CRPC, bone metastases meet primary endpoint

Internal Medicine Doctors in Flushing, NY